| abstract |
A method has been developed for preparing sterile decellularized human amniotic fluid that is suitable for long-term storage without loss of biological function. In particular, the method includes a refrigeration step that maximizes shelf life while retaining most of the important growth factors and other molecules present in fresh amniotic fluid for effective therapeutic applications. The use of the composition is intended for therapeutic purposes and reduces the pain or discomfort associated with any disorder or disease, particularly those involving the eyes and joints, or fibrotic disorders (eg, COPD). |